Zylox-Tonbridge Medical Technology Co., Ltd. logo

Zylox-Tonbridge Medical Technology Co., Ltd. (818)

Market Open
5 Jun, 06:02
XMUN XMUN
2. 22
0
0%
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
2.22
Previous Close
Add Transaction
Day Range
2.22 2.22
Year Range
2.1 2.92
Want to track 818 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

818 trading today higher at €2.22, an increase of 0% from yesterday's close, completing a monthly decrease of -12.5984% or -€0.32. Over the past 12 months, 818 stock lost -11.9048%.
818 is not paying dividends to its shareholders.
The last earnings report, released on Jun 06, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

818 Chart

Zylox-Tonbridge Medical Technology Co., Ltd. (818) FAQ

What is the stock price today?

The current price is €2.22.

On which exchange is it traded?

Zylox-Tonbridge Medical Technology Co., Ltd. is listed on XMUN.

What is its stock symbol?

The ticker symbol is 818.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Zylox-Tonbridge Medical Technology Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Zylox-Tonbridge Medical Technology Co., Ltd. Profile

Health Care Technology Industry
Healthcare Sector
Dr. Zhong Zhao Ph.D. CEO
XMUN Exchange
CNE100004JD2 ISIN
DE Country
875 Employees
27 May 2026 Last Dividend
- Last Split
- IPO Date

Overview

Zylox-Tonbridge Medical Technology Co., Ltd., established in 2012 and headquartered in Hangzhou, People's Republic of China, operates as a pioneering medical device company on both domestic and international fronts. The genesis of the company was under the name Zhejiang Zylox Medical Device Co., Ltd., which was later revised to its current designation in March 2021. Zylox-Tonbridge is dedicated to advancing the field of neuro- and peripheral-vascular interventional medical devices, leveraging its deep technical expertise to serve patients and physicians across the globe. In addition to producing cutting-edge medical devices, the company extends technical consultation and services, strengthening its position as a comprehensive provider in the healthcare sector. Furthermore, it engages in the importation of materials essential for its innovative product development processes.

Products and Services

Zylox-Tonbridge Medical Technology Co., Ltd. offers an expansive range of products and services tailored to meet the demanding needs of the neurovascular and peripheral-vascular interventional medicine sectors:

  • Neurovascular Product Portfolio: Catering to a broad spectrum of conditions such as ischemic stroke, hemorrhagic stroke, intracranial stenosis, and carotid artery diseases. This portfolio encompasses a suite of products, including intracranial access devices, aimed at addressing the complex requirements of neurovascular interventions.
  • Peripheral-Vascular Interventional Product Portfolio: Offers a comprehensive array of products for arterial and venous interventions. This includes stents, balloons, catheters, and filters designed for precision and efficacy. The portfolio also extends to hemodialysis access, aortic interventions, peripheral embolization interventions, and radiological intervention products, showcasing the company's commitment to diverse aspects of vascular health.
  • Technical Consultation and Services: Beyond its product offerings, Zylox-Tonbridge plays a pivotal role in the medical community through its provision of expert technical consultation and services. This not only demonstrates their dedication to supporting medical professionals but also ensures that patients receive care that is informed by the latest advancements in medical technology.

Contact Information

Address: Zylox-Tonbridge Industrial Park, Hangzhou, China
Phone: 86 571 8861 0082